title: [Interstitial lung disease induced by raltitrexed-oxaliplatin based chemotherapy for colorectal cancer: a case report].
authors: Servicio de Farmacia. Hospital Universitari de Bellvitge. Hospitalet de LLobregat, Barcelona.. montsecarrere@gmail.com.
authors: Montserrat
authors: M
authors: Carreres-Prieto
authors: Unidad Farmacia Oncológica. Instititut Català Oncologia. Hospital Germans Trias i Pujol. Badalona, Barcelona.. montsecarrere@gmail.com.
authors: David
authors: D
authors: López-Sisamón
authors: Servicio de Oncología Médica. Instititut Català Oncologia. Hospital Germans Trias i Pujol. Badalona, Barcelona. montsecarrere@gmail.com.
authors: Laura
authors: L
authors: Layos-Romero
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D011241:Prednisone / Q000627:therapeutic use; D011799:Quinazolines / Q000008:administration & dosage; D013876:Thiophenes / Q000008:administration & dosage
chemical_list: D000893:Anti-Inflammatory Agents; D009944:Organoplatinum Compounds; D011799:Quinazolines; D013876:Thiophenes; D000077150:Oxaliplatin; C068874:raltitrexed; D011241:Prednisone